Semaglutide is a GLP-1 receptor agonist that mimics a gut hormone to regulate appetite and blood sugar. Administered via weekly injection or daily oral tablet, it treats type 2 diabetes and supports weight loss in eligible adults with obesity or related conditions.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·This Month's Top Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends